Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 10, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 9, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 21, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 17, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 17, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 8, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 6, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 6, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 6, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 19, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 17, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 17, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 17, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 7, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 13, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 13, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 23, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 4, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 3, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 3, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 31, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 31, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 31, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 18, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005